PINK1 (Q9BXM7) variants and mutations
PINK1 (also known as Q9BXM7) is a human protein-coding gene encoding a serine/threonine-protein kinase PINK1, mitochondrial protein. It accumulates on damaged mitochondria and recruits parkin to initiate selective mitophagy and mitochondrial quality control. Biallelic loss-of-function variants cause autosomal recessive early-onset Parkinson disease. This analysis covers 1,224 PINK1 variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes Young adult-onset Parkinsonism, Parkinson disease 6, and Dystonia. Example PINK1 variants include A2V, A2E, and A2A.
Variant analysis overview
- Gene: PINK1
- Protein: Q9BXM7
- UniProt accession: Q9BXM7
- Organism: Homo sapiens
- Variants analyzed: 1224
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 775 unspecified-consequence records; 269 missense variants; 119 synonymous variants; 18 stop-gained variants; 31 frameshift variants; 6 in-frame deletions; 2 in-frame insertions; 3 substitution
- Prediction scores: 1,056 variants have prediction scores (86% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Young adult-onset Parkinsonism, Parkinson disease 6, Dystonia, Parkinson disease, young-onset Parkinson disease, hereditary disease, late-onset Parkinson disease, neuroblastoma, Hereditary late-onset Parkinson disease, hepatocellular carcinoma, acute kidney injury, neoplasm.
Protein structure and variant hotspots
- Protein features: 1 domains; 2 binding sites; 2 post-translational modification sites.
- Structural context: 454 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PINK1 variants
Examples include A2V, A2E, A2A, V3M, V3L, V3V, R4*, R4R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2V (p.Ala2Val), gnomAD 1-20633553-C-T, REVEL 0.14, CADD 23.60
- A2E (p.Ala2Glu), gnomAD 1-20633553-C-A, REVEL 0.20, CADD 23.90
- A2A (p.Ala2Ala), gnomAD 1-20633554-G-T, CADD 15.80
- V3M (p.Val3Met), gnomAD 1-20633555-G-A, REVEL 0.14, CADD 23.60
- V3L (p.Val3Leu), gnomAD 1-20633555-G-T, REVEL 0.08, CADD 22.10
- V3V (p.Val3Val), gnomAD 1-20633557-G-T, CADD 14.60
- R4* (p.Arg4Ter), gnomAD 1-20633558-C-T, CADD 36.00
- R4R (p.Arg4Arg), gnomAD 1-20633558-C-A, CADD 18.30
- R4P (p.Arg4Pro), gnomAD 1-20633559-G-C, REVEL 0.40, CADD 32.00
- R4Q (p.Arg4Gln), gnomAD 1-20633559-G-A, REVEL 0.31, CADD 32.00
- R4L (p.Arg4Leu), gnomAD 1-20633559-G-T, REVEL 0.45, CADD 31.00
- Q5* (p.Gln5Ter), rs1005937012, ClinGen CA18987686, ClinVar RCV000818442, TOPMed rs1005937012, CADD 37.00, Pathogenic
- Q5G (p.Gln5Gly), gnomAD 1-20633559-GAC-G, CADD 29.20
- Q5K (p.Gln5Lys), gnomAD 1-20633561-C-A, REVEL 0.22, CADD 22.50
- Q5E (p.Gln5Glu), gnomAD 1-20633561-C-G, REVEL 0.20, CADD 22.60
- Q5R (p.Gln5Arg), gnomAD 1-20633562-A-G, REVEL 0.26, CADD 22.80
- Q5H (p.Gln5His), gnomAD 1-20633563-G-T, REVEL 0.16, CADD 20.30
- Q5Q (p.Gln5Gln), gnomAD 1-20633563-G-A, CADD 14.50
- A6V (p.Ala6Val), TOPMed rs1038480938, REVEL 0.20, CADD 22.80, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- A6E (p.Ala6Glu), gnomAD 1-20633565-C-A, REVEL 0.42, CADD 23.90
- A6A (p.Ala6Ala), rs1297865995, gnomAD 1-20633566-G-T, CADD 14.50
- L7M (p.Leu7Met), TOPMed rs1347237673, gnomAD rs1347237673, REVEL 0.26, CADD 26.60
- L7L (p.Leu7Leu), rs1347237673, gnomAD 1-20633567-C-T, CADD 15.90
- L7P (p.Leu7Pro), gnomAD 1-20633568-T-C, REVEL 0.62, CADD 32.00
- G8S (p.Gly8Ser), TOPMed rs2053013079, REVEL 0.07, CADD 21.40
- G8C (p.Gly8Cys), gnomAD 1-20633570-G-T, REVEL 0.33, CADD 27.00
- G8D (p.Gly8Asp), gnomAD 1-20633571-G-A, REVEL 0.27, CADD 23.20
- G8G (p.Gly8Gly), gnomAD 1-20633572-C-T, CADD 16.40
- R9G (p.Arg9Gly), rs2154533488, ClinGen CA338853365, ClinVar RCV001870326, Ensembl rs2154533488, AlphaMissense 0.27, MetaLR 0.36, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- R9H (p.Arg9His), gnomAD 1-20633574-G-A, REVEL 0.45, CADD 28.30
- R9R (p.Arg9Arg), gnomAD 1-20633575-C-T, CADD 12.40
- G10A (p.Gly10Ala), TOPMed rs2053013176
- G10R (p.Gly10Arg), TOPMed rs2053013114, gnomAD rs2053013114, REVEL 0.51, CADD 29.70, Uncertain significance, Inborn genetic diseases
- G10S (p.Gly10Ser), TOPMed rs2053013114, gnomAD rs2053013114, REVEL 0.43, CADD 25.50
- p.Gly10 Arg15del, gnomAD 1-20633572-CCGCGG, CADD 22.30
- G10D (p.Gly10Asp), gnomAD 1-20633577-G-A, REVEL 0.54, CADD 26.90
- G10V (p.Gly10Val), gnomAD 1-20633577-G-T, REVEL 0.31, CADD 22.80
- G10G (p.Gly10Gly), gnomAD 1-20633578-C-T, CADD 16.30
- L11M (p.Leu11Met), rs886044686, ClinGen CA10607059, ClinVar RCV000389665, Ensembl rs886044686, REVEL 0.36, CADD 26.60, Uncertain significance, not provided
- L11Q (p.Leu11Gln), Ensembl rs2053013259, REVEL 0.52, CADD 31.00
- L11P (p.Leu11Pro), gnomAD 1-20633580-T-C, REVEL 0.59, CADD 32.00
- L11L (p.Leu11Leu), gnomAD 1-20633581-G-A, CADD 14.80
- Q12L (p.Gln12Leu), TOPMed rs1391821022
- Q12R (p.Gln12Arg), TOPMed rs1391821022, REVEL 0.19, CADD 24.40
- Q12K (p.Gln12Lys), gnomAD 1-20633582-C-A, REVEL 0.11, CADD 23.60
- Q12* (p.Gln12Ter), gnomAD 1-20633582-C-T, CADD 37.00
- Q12H (p.Gln12His), gnomAD 1-20633584-G-T, REVEL 0.15, CADD 23.30
- Q12Q (p.Gln12Gln), rs2053013365, gnomAD 1-20633584-G-A, CADD 14.60
- L13M (p.Leu13Met), gnomAD rs2053013403, REVEL 0.29, CADD 24.40
- L13Q (p.Leu13Gln), gnomAD 1-20633586-T-A, REVEL 0.30, CADD 25.50
- L13P (p.Leu13Pro), gnomAD 1-20633586-T-C, REVEL 0.42, CADD 26.00
- L13L (p.Leu13Leu), gnomAD 1-20633587-G-T, CADD 13.00
- G14S (p.Gly14Ser), TOPMed rs2053013433, gnomAD rs2053013433
- G14C (p.Gly14Cys), gnomAD 1-20633588-G-T, REVEL 0.53, CADD 27.70
- G14D (p.Gly14Asp), gnomAD 1-20633589-G-A, REVEL 0.27, CADD 23.70
- G14G (p.Gly14Gly), rs2053013456, gnomAD 1-20633590-T-C, CADD 15.10
- R15* (p.Arg15Ter), gnomAD 1-20633591-C-T, CADD 38.00
- R15R (p.Arg15Arg), gnomAD 1-20633591-C-A, CADD 16.40
- R15L (p.Arg15Leu), gnomAD 1-20633592-G-T, REVEL 0.48, CADD 25.40
- R15Q (p.Arg15Gln), gnomAD 1-20633592-G-A, REVEL 0.36, CADD 25.40
- A16G (p.Ala16Gly), TOPMed rs897203855, gnomAD rs897203855, REVEL 0.30, CADD 24.20, Likely benign
- A16V (p.Ala16Val), rs897203855, ClinGen CA18987691, ClinVar RCV001883055, ClinVar RCV003365489, REVEL 0.32, CADD 23.10, Conflicting interpretations, Autosomal recessive early-onset Parkinson disease 6; Inborn genetic diseases
- A16P (p.Ala16Pro), gnomAD 1-20633594-G-C, REVEL 0.43, CADD 26.60
- A16T (p.Ala16Thr), gnomAD 1-20633594-G-A, REVEL 0.26, CADD 25.70
- A16E (p.Ala16Glu), gnomAD 1-20633595-C-A, REVEL 0.27, CADD 24.20
- A16A (p.Ala16Ala), rs2053014692, gnomAD 1-20633596-G-C, CADD 15.20
- L17Q (p.Leu17Gln), Ensembl rs1570396856
- L17P (p.Leu17Pro), gnomAD 1-20633598-T-C, REVEL 0.60, CADD 31.00
- L17L (p.Leu17Leu), gnomAD 1-20633599-G-A, CADD 13.40
- L18Q (p.Leu18Gln), Ensembl rs1570396862
- L18M (p.Leu18Met), gnomAD 1-20633600-C-A, REVEL 0.25, CADD 23.20
- L18L (p.Leu18Leu), gnomAD 1-20633600-C-T, CADD 14.80
- L18V (p.Leu18Val), gnomAD 1-20633600-C-G, REVEL 0.15, CADD 22.70
- L19Q (p.Leu19Gln), Ensembl rs1570396870
- p.Leu19dup, gnomAD 1-20633595-C-CGCT, CADD 20.20
- L19del (p.Leu19del), gnomAD 1-20633595-CGCT-C, CADD 21.90
- L19L (p.Leu19Leu), gnomAD 1-20633603-C-T, CADD 15.10
- L19M (p.Leu19Met), gnomAD 1-20633603-C-A, REVEL 0.36, CADD 24.10
- L19P (p.Leu19Pro), gnomAD 1-20633604-T-C, REVEL 0.48, CADD 25.40
- R20L (p.Arg20Leu), Ensembl rs1245195510, REVEL 0.27, CADD 22.90
- p.Arg20 Phe21insTer, rs2053013473, gnomAD 1-20633591-C-CGAG, CADD 32.00
- R20S (p.Arg20Ser), gnomAD 1-20633606-C-A, REVEL 0.33, CADD 23.60
- R20C (p.Arg20Cys), gnomAD 1-20633606-C-T, REVEL 0.41, CADD 27.80
- R20G (p.Arg20Gly), gnomAD 1-20633606-C-G, REVEL 0.40, CADD 24.30
- R20H (p.Arg20His), gnomAD 1-20633607-G-A, REVEL 0.29, CADD 24.30
- R20R (p.Arg20Arg), gnomAD 1-20633608-C-A, CADD 14.20
- F21L (p.Phe21Leu), TOPMed rs2053014865, gnomAD rs2053014865, REVEL 0.18, CADD 19.00, Likely benign
- F21F (p.Phe21Phe), rs2053014865, gnomAD 1-20633611-C-T, CADD 13.70
- T22M (p.Thr22Met), rs2545244807, ClinGen CA338853443, ClinVar RCV002908522, REVEL 0.18, CADD 22.50, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- T22S (p.Thr22Ser), gnomAD 1-20633612-A-T, REVEL 0.08, CADD 13.30
- T22K (p.Thr22Lys), gnomAD 1-20633613-C-A, REVEL 0.10, CADD 17.40
- T22T (p.Thr22Thr), gnomAD 1-20633614-G-C, CADD 3.66
- G23S (p.Gly23Ser), rs551542832, ClinGen CA18987709, ClinVar RCV000518777, ClinVar RCV001098230, REVEL 0.05, CADD 10.20, Conflicting interpretations, not specified; Autosomal recessive early-onset Parkinson disease 6
- G23V (p.Gly23Val), gnomAD rs1339849774, REVEL 0.05, CADD 12.80
- G23D (p.Gly23Asp), gnomAD 1-20633616-G-A, REVEL 0.05, CADD 13.20
- G23G (p.Gly23Gly), rs1364669661, gnomAD 1-20633617-C-T, CADD 17.30
- K24* (p.Lys24Ter), gnomAD rs1405510308, CADD 35.00
- K24K (p.Lys24Lys), gnomAD 1-20633620-G-A, CADD 10.40
- K24N (p.Lys24Asn), gnomAD 1-20633620-G-T, REVEL 0.24, CADD 22.90
- P25H (p.Pro25His), TOPMed rs2053015060
- P25L (p.Pro25Leu), TOPMed rs2053015060, REVEL 0.29, CADD 22.50
- P25T (p.Pro25Thr), gnomAD 1-20633621-C-A, REVEL 0.25, CADD 20.40
- P25P (p.Pro25Pro), rs1178515076, gnomAD 1-20633623-C-G, CADD 2.28
- G26R (p.Gly26Arg), rs2053015141, ClinGen CA338853465, ClinVar RCV001315604, Ensembl rs2053015141, REVEL 0.37, CADD 23.70, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- G26S (p.Gly26Ser), gnomAD 1-20633624-G-A, REVEL 0.12, CADD 18.40
- G26C (p.Gly26Cys), gnomAD 1-20633624-G-T, REVEL 0.40, CADD 24.00
- G26V (p.Gly26Val), gnomAD 1-20633625-G-T, REVEL 0.34, CADD 23.30
- G26D (p.Gly26Asp), gnomAD 1-20633625-G-A, REVEL 0.29, CADD 23.20
- G26G (p.Gly26Gly), gnomAD 1-20633626-C-A, CADD 8.11
- R27W (p.Arg27Trp), TOPMed rs2053015185, REVEL 0.21, CADD 20.60
- R27R (p.Arg27Arg), rs2053015185, gnomAD 1-20633627-C-A, CADD 9.01
- R27L (p.Arg27Leu), gnomAD 1-20633628-G-T, REVEL 0.03, CADD 13.10
- R27Q (p.Arg27Gln), gnomAD 1-20633628-G-A, REVEL 0.05, CADD 12.70
- A28T (p.Ala28Thr), Ensembl rs2053015233, REVEL 0.07, CADD 1.87
- A28V (p.Ala28Val), Ensembl rs2053015285, REVEL 0.08, CADD 1.50
- A28S (p.Ala28Ser), gnomAD 1-20633630-G-T, REVEL 0.03, CADD 0.64
- A28A (p.Ala28Ala), rs1241706670, gnomAD 1-20633632-C-G, CADD 9.79
- Y29D (p.Tyr29Asp), rs2545244881, ClinGen CA338853480, ClinVar RCV002697681, Uncertain significance, Inborn genetic diseases
- Y29R (p.Tyr29Arg), rs1480758482, gnomAD 1-20633622-CCGGCC, CADD 26.70
- Y29G (p.Tyr29Gly), gnomAD 1-20633631-CCTACG, CADD 25.40
- Y29T (p.Tyr29Thr), rs1245404301, gnomAD 1-20633632-CT-C, CADD 20.00
- Y29H (p.Tyr29His), gnomAD 1-20633633-T-C, REVEL 0.12, CADD 13.90
- Y29* (p.Tyr29Ter), gnomAD 1-20633635-C-A, CADD 33.00
- Y29Y (p.Tyr29Tyr), rs1444350639, gnomAD 1-20633635-C-T, CADD 7.85
- G30D (p.Gly30Asp), Ensembl rs1570396903
- G30R (p.Gly30Arg), rs569753606, ClinGen CA10608797, ClinVar RCV000983814, ClinVar RCV003409446, REVEL 0.16, CADD 20.10, Conflicting interpretations, Autosomal recessive early-onset Parkinson disease 6; not provided
- G30S (p.Gly30Ser), rs569753606, ClinGen CA338853489, ClinVar RCV003499312, 1000Genomes rs569753606, REVEL 0.03, CADD 14.70, Likely benign, Autosomal recessive early-onset Parkinson disease 6
- G30V (p.Gly30Val), Ensembl rs1570396903, REVEL 0.04, CADD 14.00
- G30C (p.Gly30Cys), gnomAD 1-20633636-G-T, REVEL 0.18, CADD 22.90
- G30G (p.Gly30Gly), gnomAD 1-20633638-C-A, CADD 13.20
- L31F (p.Leu31Phe), ExAC rs577010119, gnomAD rs577010119, REVEL 0.09, CADD 16.60
- L31V (p.Leu31Val), rs2545244892, ClinGen CA338853495, ClinVar RCV002713041, Uncertain significance, Inborn genetic diseases
- L31L (p.Leu31Leu), gnomAD 1-20633639-T-C, CADD 14.60
- L31W (p.Leu31Trp), gnomAD 1-20633640-T-G, REVEL 0.14, CADD 15.80
- G32E (p.Gly32Glu), TOPMed rs2053015599, REVEL 0.36, CADD 24.00
- G32R (p.Gly32Arg), TOPMed rs1427965886, gnomAD rs1427965886, REVEL 0.59, CADD 22.90
- G32W (p.Gly32Trp), gnomAD 1-20633642-G-T, REVEL 0.48, CADD 26.50
- G32G (p.Gly32Gly), gnomAD 1-20633644-G-T, CADD 7.95
- R33G (p.Arg33Gly), gnomAD 1-20633640-TG-T, CADD 24.30
- R33P (p.Arg33Pro), gnomAD 1-20633645-CGG-C, CADD 22.90
- R33W (p.Arg33Trp), gnomAD 1-20633645-C-T, REVEL 0.29, CADD 23.70
- R33L (p.Arg33Leu), gnomAD 1-20633646-G-T, REVEL 0.14, CADD 17.80
- R33Q (p.Arg33Gln), gnomAD 1-20633646-G-A, REVEL 0.11, CADD 17.90
- R33R (p.Arg33Arg), gnomAD 1-20633647-G-A, CADD 10.80
- P34L (p.Pro34Leu), TOPMed rs1006830855, gnomAD rs1006830855, REVEL 0.14, CADD 21.30, Uncertain significance
- P34R (p.Pro34Arg), rs1006830855, ClinGen CA18987717, ClinVar RCV001893903, TOPMed rs1006830855, REVEL 0.07, CADD 16.90, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- P34A (p.Pro34Ala), gnomAD 1-20633648-C-G, REVEL 0.05, CADD 17.50
- P34S (p.Pro34Ser), gnomAD 1-20633648-C-T, REVEL 0.04, CADD 15.30
- P34T (p.Pro34Thr), gnomAD 1-20633648-C-A, REVEL 0.08, CADD 17.70
- P34Q (p.Pro34Gln), gnomAD 1-20633649-C-A, REVEL 0.10, CADD 16.60
- P34P (p.Pro34Pro), gnomAD 1-20633650-G-T, CADD 8.79
- G35D (p.Gly35Asp), Ensembl rs2053015724, REVEL 0.45, CADD 22.80
- G35S (p.Gly35Ser), Ensembl rs2053015697, REVEL 0.29, CADD 22.90
- p.Gly35 Ala37del, gnomAD 1-20633648-CCGGGC, CADD 18.60
- G35C (p.Gly35Cys), gnomAD 1-20633651-G-T, REVEL 0.43, CADD 23.40
- G35R (p.Gly35Arg), gnomAD 1-20633651-G-C, REVEL 0.40, CADD 23.20
- G35V (p.Gly35Val), gnomAD 1-20633652-G-T, REVEL 0.36, CADD 22.50
- G35A (p.Gly35Ala), gnomAD 1-20633652-G-C, REVEL 0.27, CADD 22.10
- G35G (p.Gly35Gly), gnomAD 1-20633653-C-T, CADD 13.60
- p.Pro36 Gly39del, gnomAD 1-20633648-CCGGGC, CADD 18.70
- P36R (p.Pro36Arg), gnomAD 1-20633652-GC-G, CADD 23.20
- P36T (p.Pro36Thr), gnomAD 1-20633654-C-A, REVEL 0.24, CADD 22.60
- P36S (p.Pro36Ser), gnomAD 1-20633654-C-T, REVEL 0.20, CADD 20.60
- P36Q (p.Pro36Gln), gnomAD 1-20633655-C-A, REVEL 0.27, CADD 20.60
- P36L (p.Pro36Leu), gnomAD 1-20633655-C-T, REVEL 0.33, CADD 21.70
- P36P (p.Pro36Pro), gnomAD 1-20633656-G-A, CADD 13.20
- A37V (p.Ala37Val), TOPMed rs2053015747, REVEL 0.13, CADD 14.60
- A37R (p.Ala37Arg), gnomAD 1-20633622-C-CCGG, CADD 23.10
- A37S (p.Ala37Ser), gnomAD 1-20633657-G-T, REVEL 0.09, CADD 14.80
- A37T (p.Ala37Thr), gnomAD 1-20633657-G-A, REVEL 0.10, CADD 17.00
- A37E (p.Ala37Glu), gnomAD 1-20633658-C-A, REVEL 0.17, CADD 12.90
- A37A (p.Ala37Ala), gnomAD 1-20633659-G-T, CADD 13.90
- A38T (p.Ala38Thr), rs1355118616, ClinGen CA338853534, ClinVar RCV003318294, ClinVar RCV004333277, REVEL 0.17, CADD 18.60, Uncertain significance, not provided; Inborn genetic diseases
- A38V (p.Ala38Val), rs1275557772, ClinGen CA338853539, ClinVar RCV003499599, TOPMed rs1275557772, REVEL 0.17, CADD 19.10, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- A38S (p.Ala38Ser), gnomAD 1-20633660-G-T, REVEL 0.15, CADD 16.60
- A38G (p.Ala38Gly), gnomAD 1-20633661-C-G, REVEL 0.14, CADD 20.50
- A38A (p.Ala38Ala), rs758019868, gnomAD 1-20633662-G-A, CADD 10.40
- G39V (p.Gly39Val), rs2053015980, ClinGen CA338853544, ClinVar RCV001918474, gnomAD rs2053015980, REVEL 0.10, CADD 16.20, Uncertain significance, Autosomal recessive early-onset Parkinson disease 6
- G39A (p.Gly39Ala), gnomAD 1-20633661-CG-C, CADD 19.90
- G39R (p.Gly39Arg), gnomAD 1-20633662-G-GCGG, CADD 23.00
Public PINK1 analysis runs
- PINK1 analysis run — PINK1 (1,224 variants) — completed 2026-08-19